Outcomes after switching from one anti–t
✍
Kimme L. Hyrich; Mark Lunt; Kath D. Watson; Deborah P. M. Symmons; Alan J. Silma
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 81 KB
👁 1 views
## Abstract ## Objective Patients with rheumatoid arthritis (RA) who experience treatment failure with one anti–tumor necrosis factor (anti‐TNF) agent, due to either inefficacy or toxicity, are frequently switched to a second anti‐TNF agent, although the benefits of switching are unknown. The pres